SCHEMBL26621024

SCHEMBL26621024

CC(C)=CCc1c(O)cc2oc(-c3ccc(C)c(O)c3)c(O)c(=O)c2c1O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 3/20 0.73
ABCG2 Q9UNQ0 2/20 0.66
PTPN1 P18031 6/20 0.62
PDE4D Q08499 2/20 0.61
PDE5A O76074 1/20 0.61
CYP19A1 P11511 5/20 0.60
FASN P49327 3/20 0.60
NUDT1 P36639 3/20 0.60
IDH1 O75874 2/20 0.60
GAA P10253 2/20 0.60
SI P14410 2/20 0.60
AKR1B1 P15121 2/20 0.60
PGAM1 P18669 2/20 0.60
MGAM2 Q2M2H8 2/20 0.60
SIRT2 Q8IXJ6 2/20 0.60
TTR P02766 1/20 0.60
PTGS1 P23219 1/20 0.60
PTGS2 P35354 1/20 0.60
SIRT1 Q96EB6 1/20 0.60
SIRT3 Q9NTG7 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gancaonin P SCHEMBL1170933 0.91 MGAM (0.76) MGAMABCG2PTPN1PDE4DPDE5A
SCHEMBL26621022 0.89 MGAM (0.72) MGAMABCG2PTPN1PDE4DPDE5A
Licoflavonol SCHEMBL8050093 0.88 ABCG2 (0.82) MGAMABCG2PTPN1PDE4DPDE5A
Licoflavonol SCHEMBL29392785 0.88 ABCG2 (0.82) MGAMABCG2PTPN1PDE4DPDE5A
SCHEMBL24075660 0.87 MGAM (0.80) MGAMABCG2PTPN1PDE4DPDE5A
SCHEMBL29833229 0.87 MGAM (0.80) MGAMABCG2PTPN1PDE4DPDE5A
SCHEMBL5072293 0.85 MGAM (0.74) MGAMABCG2PTPN1PDE4DPDE5A
Broussonol E SCHEMBL30341880 0.84 MGAM (1.00) MGAMABCG2PTPN1PDE4DCYP19A1
Broussonol E SCHEMBL25404646 0.84 MGAM (1.00) MGAMABCG2PTPN1PDE4DCYP19A1
SCHEMBL30020726 0.84 PTPN1 (0.67) MGAMABCG2PTPN1PDE4DPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795127-B2 Processes for the preparation of ortho-allylated hydroxy aryl compounds MCMASTER UNIVERSITY (CA) 2023-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795127-B2 Processes for the preparation of ortho-allylated hydroxy aryl compounds ADH1A, ADH1C, AHR MGAM 3381/4885ABCG2 1860/4885PTPN1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.